Filed: 2/12/2026ACC: 0001104659-26-014146
📋 What this filing means
DECHENG CAPITAL LLC filed this quarterly 13F‑HR report disclosing 19 equity positions with a total reported market value of $743.41M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
19
Positions
$743.41M
Total AUM (reported)
56.57M
Total Shares
Allocation by class
COM$737.00M99.1%
SHS$6.20M0.8%
WARRANTS$213.2K0.0%
Portfolio Concentration
Top 3$582.44M78.3%
4–10$141.38M19.0%
11–25$19.59M2.6%
Top 3 weight
78.3%
Top 10 weight
97.4%
Voting Authority Distribution
Total shares with voting rights: 56.57M
Sole
Full voting authority
56.57M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole19
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings19
Rows:
CG ONCOLOGY INC
SOLEShares6.37M
TypeSH
Market value$264.55M
35.59%
Sole
6.37M
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares25.95M
TypeSH
Market value$232.55M
31.28%
Sole
25.95M
Shared
0.00
None
0.00
Upstream Bio Inc.
SOLEShares3.14M
TypeSH
Market value$85.33M
11.48%
Sole
3.14M
Shared
0.00
None
0.00
AARDVARK THERAPEUTICS INC
SOLEShares3.92M
TypeSH
Market value$51.41M
6.92%
Sole
3.92M
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
SOLEShares692.05K
TypeSH
Market value$21.30M
2.87%
Sole
692.05K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA CO NV
SOLEShares592.06K
TypeSH
Market value$20.77M
2.79%
Sole
592.06K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC(NSM)
SOLEShares200K
TypeSH
Market value$15.93M
2.14%
Sole
200K
Shared
0.00
None
0.00
Arcus Biosciences, Inc
SOLEShares541.56K
TypeSH
Market value$12.91M
1.74%
Sole
541.56K
Shared
0.00
None
0.00
Aclaris Therapeutics, Inc.
SOLEShares4.04M
TypeSH
Market value$12.17M
1.64%
Sole
4.04M
Shared
0.00
None
0.00
Equillium Inc.
SOLEShares4.45M
TypeSH
Market value$6.89M
0.93%
Sole
4.45M
Shared
0.00
None
0.00
BeyondSpring Inc.
SOLEShares3.80M
TypeSH
Market value$6.20M
0.83%
Sole
3.80M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares92.70K
TypeSH
Market value$4.32M
0.58%
Sole
92.70K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares17.30K
TypeSH
Market value$4.27M
0.57%
Sole
17.30K
Shared
0.00
None
0.00
Aura Biosciences, Inc.
SOLEShares360.48K
TypeSH
Market value$1.96M
0.26%
Sole
360.48K
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc.
SOLEShares1.32M
TypeSH
Market value$1.79M
0.24%
Sole
1.32M
Shared
0.00
None
0.00
Pyxis Oncology, Inc (formerly Apexigen)
SOLEShares326.81K
TypeSH
Market value$375.8K
0.05%
Sole
326.81K
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares44.31K
TypeSH
Market value$332.3K
0.04%
Sole
44.31K
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares646.06K
TypeSH
Market value$213.2K
0.03%
Sole
646.06K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares59.90K
TypeSH
Market value$141.4K
0.02%
Sole
59.90K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 6.37M | SH | $264.55M 35.59% | 6.37M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | COM | 25.95M | SH | $232.55M 31.28% | 25.95M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | COM | 3.14M | SH | $85.33M 11.48% | 3.14M | 0.00 | 0.00 |
AARDVARK THERAPEUTICS INCSOLE | COM | 3.92M | SH | $51.41M 6.92% | 3.92M | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 692.05K | SH | $21.30M 2.87% | 692.05K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA CO NVSOLE | COM | 592.06K | SH | $20.77M 2.79% | 592.06K | 0.00 | 0.00 |
REVOLUTION MEDICINES INC(NSM)SOLE | COM | 200K | SH | $15.93M 2.14% | 200K | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 541.56K | SH | $12.91M 1.74% | 541.56K | 0.00 | 0.00 |
Aclaris Therapeutics, Inc.SOLE | COM | 4.04M | SH | $12.17M 1.64% | 4.04M | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $6.89M 0.93% | 4.45M | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 3.80M | SH | $6.20M 0.83% | 3.80M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 92.70K | SH | $4.32M 0.58% | 92.70K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 17.30K | SH | $4.27M 0.57% | 17.30K | 0.00 | 0.00 |
Aura Biosciences, Inc.SOLE | COM | 360.48K | SH | $1.96M 0.26% | 360.48K | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 1.32M | SH | $1.79M 0.24% | 1.32M | 0.00 | 0.00 |
Pyxis Oncology, Inc (formerly Apexigen)SOLE | COM | 326.81K | SH | $375.8K 0.05% | 326.81K | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 44.31K | SH | $332.3K 0.04% | 44.31K | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | WARRANTS | 646.06K | SH | $213.2K 0.03% | 646.06K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM | 59.90K | SH | $141.4K 0.02% | 59.90K | 0.00 | 0.00 |